Legal Opinion
In re Accutane Litig.
Supreme Court of New Jersey
Decided October 3, 2018No. A-26/27 September Term 2017; 079933PublishedCited by 42 opinions
1Opinion of the CourtJustice Albin
**234This appeal arises from 532 product-liability claims filed against defendants Hoffmann-La Roche Inc. and Roche Laboratories Inc. (collectively Roche), corporations with their principal places of business in New Jersey. Roche developed, manufactured, marketed, and labeled Accutane, a prescription medication for the treatment of severe and persistent cases of acne. Plaintiffs allege that Accutane, prescribed by their physicians for the treatment of acne, caused them to contract inflammatory *506bowel disease (IBD) and that Roche failed to give adequate label warnings to advise them of the…
2Cases cited63 opinions
- Bristol-Myers Squibb Co. v. Superior Court of Cal., San Francisco Cty.Supreme Court of the United States · 2017
- Brill v. Guardian Life Insurance Co. of AmericaSupreme Court of New Jersey · 1995
- Wyeth v. LevineSupreme Court of the United States · 2009
- Thom v. Bristol-Myers Squibb Co.Court of Appeals for the Tenth Circuit · 2003
- Stahl v. Novartis Pharmaceuticals Corp.Court of Appeals for the Fifth Circuit · 2002
58 more not listed; retrieve them via the Exa API.
3Cited by42 opinions
- DAVID F. CALABOTTA VS. PHIBRO ANIMAL HEALTH CORPORATION (L-1979-17, BERGEN COUNTY AND STATEWIDE)New Jersey Superior Court Appellate Division · 2019
- TRACEY L. VIZZONI, ETC. VS. B.M.D. (L-0575-15, SOMERSET COUNTY AND STATEWIDE)New Jersey Superior Court Appellate Division · 2019
- ABURADWAN v. RAMIREZDistrict Court, D. New Jersey · 2024
- ALSAIDI v. HUBERTDistrict Court, D. New Jersey · 2024
- Arch Insurance Company (Europe) Ltd., et al. v. Thomas K. ReillyDistrict Court, D. New Jersey · 2026
37 more not listed; retrieve them via the Exa API.